Key result
High plasma CCL21 is linked to ~164% higher risk of first-time coronary events.
Why the study?
Associations between the homeostatic chemokines CCL21 or CCL19 and first-time coronary event incidence had not been investigated previously in populations without established cardiovascular disease.
Do plasma levels of CCL21 and CCL19 predict future coronary events in individuals without previous coronary heart disease?
Cohort (n=4,636)
No
Do plasma levels of CCL21 and CCL19 predict future coronary events in individuals without previous coronary heart disease?
Plasma CCL21 levels independently predict future first-time coronary events in individuals without a history of coronary heart disease, suggesting its potential utility as a biomarker for cardiovascular risk prediction.
Answers are grounded in this paper and cite their sources.
May inform primary prevention risk stratification; extends CCL21 biomarker observations from secondary to incident coronary disease.
BACKGROUND AND AIMS: The homeostatic chemokines CCL21 and CCL19 have been explored as biomarkers in cardiovascular disease prediction in patients with established cardiovascular disease, but associations between these chemokines and first-time coronary event incidence have not been investigated before. Here, we explored associations between CCL21 or CCL19 and first-time incident coronary events in the general population-based Malmö Diet and Cancer cohort with two decades of follow-up. METHODS: CCL21 and CCL19 levels in plasma were analysed with ELISA and proximity extension assay and associations with disease incidence were explored with conditional logistic regression in a nested case-control cohort (CCL21; n = 676) and with Cox regression in a population-based cohort (CCL19; n = 4636). RESULTS: High CCL21 levels in plasma were associated with incident first-time coronary events independently of traditional risk factors (odds ratio of 2.64 with 95% confidence interval 1.62-4.31, p < 0.001, comparing the highest versus the lowest tertile of CCL21), whereas CCL19 was not. CCL19 was, however, associated with incident heart failure, as well as increased all-cause, cardiovascular and cancer mortality independently of age and sex. CONCLUSIONS: Even though CCL21 and CCL19 both signal through CCR7, these chemokines may not be interchangeable as disease predictors and CCL21 could be used for prediction of future coronary events in individuals without any previous coronary heart disease history.
No takes yet. Share an insight, caveat, or question.
Katra et al. (2023) conducted a cohort in First-time coronary events (n=4,636). High plasma CCL21 levels vs. Lowest tertile of plasma CCL21 was evaluated on Incident first-time coronary events (OR 2.64, 95% CI 1.62-4.31, p=<0.001). High plasma levels of CCL21 were associated with incident first-time coronary events independently of traditional risk factors, whereas CCL19 was not.
Synapse has enriched 10 related papers. Consider them for comparative context: